1-3 of 3
Søren Lykke Petersen, MD DMSc.
Close
Sort by
Journal Articles

Pre-Transplantation ST2 Levels and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Lars Klingen Gjærde, MD, Sisse Rye Ostrowski, MD PhD DMSc, Ass Prof, Niels Smedegaard Andersen, MD PhD DMSc, Lone Smidstrup Friis, MD PhD, Brian Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc, Ida Schjødt, MD PhD, Henrik Sengeløv, MD DMSc, Prof
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133876
Published: 2020
Journal Articles

Improved Relapse-Free Survival and Overall Survival in Patients with High Immune Reconstitution of Gamma Delta T Cells 2 Months after Allogeneic Hematopoietic Stem Cell Transplantation

Lia Minculescu, MD, Hanne Vibeke Marquart, MD PhD, Lars Peter Ryder, MSc, PhD, Ida Schjødt, MD PhD, Lone Smidstrup Friis, MD PhD, Brian Thomas Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc., Niels Smedegaard Andersen, MD PhD, Eva Kannik Hastrup, MD PhD, Anne Fischer-Nielsen, MD PhD, Henrik Sengeloev, MD DMSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 3396.
https://doi.org/10.1182/blood-2018-99-111777
Published: 2018
Journal Articles

Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial

Brenda M Sandmaier, MD, David G Maloney, MD PhD, Barry E. Storer, PhD, Gitte Olesen, MD, Michael B. Maris, MD, Jonathan A Gutman, MD, Soren Lykke Petersen, MD DMSC, Amelia Langston, MD, Thomas Chauncey, Wolfgang Bethge, MD, Michael A Pulsipher, MD, Brian Thomas Kornblit, MD PhD, Ann E Woolfrey, MD, Marco Mielcarek, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD, Rainer F. Storb, MD
Journal: Blood
Blood (2016) 128 (22): 506.
https://doi.org/10.1182/blood.V128.22.506.506
Published: 2016